Community Healthcare Trust Inc (CHCT) financial statements: income statement, balance sheet and cash flow
Community Healthcare Trust Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Community Healthcare Trust Inc reported revenue of $121.2M (+4.7% year on year) and net income of $5.1M (+260.4% year on year).
Income statement
Community Healthcare Trust Inc income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Rental income
$121.4M
$114.6M
$108.7M
$94.1M
Other operating interest
($156.0K)
—
$4.2M
$3.6M
Total revenue
$121.2M
$115.8M
$112.8M
$97.7M
Property operating
$23.6M
$22.8M
$20.7M
$16.6M
General and administrative
$25.1M
$19.1M
$27.3M
$14.8M
Depreciation and amortization
$43.5M
$42.8M
$39.7M
$32.3M
Total expenses
$92.3M
$84.7M
$87.7M
$63.8M
Gains on the sales of depreciable real estate assets, net of losses and impairments
$11.8M
—
—
—
Interest expense
($27.0M)
($23.7M)
($17.8M)
($11.9M)
Credit loss reserve
($8.7M)
($11.0M)
—
—
Deferred income tax expense
($23.0K)
$0
($306.0K)
($41.0K)
Interest and other income, net
$34.0K
$530.0K
$813.0K
$66.0K
Total
($23.8M)
($34.3M)
($17.4M)
—
NET INCOME (LOSS)
$5.1M
($3.2M)
$7.7M
$22.0M
Net (loss) income per common share - Basic (in dollars per share)
$0.08
-$0.23
$0.20
$0.81
Net (loss) income per common share - Diluted (in dollars per share)
$0.08
-$0.23
$0.20
$0.81
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)
26.9M
26.5M
25.2M
23.6M
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)
26.9M
26.5M
25.2M
23.6M
Community Healthcare Trust Inc income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Rental income
$31.0M
$31.3M
$30.8M
$30.1M
Other operating interest
$253.0K
$255.0K
$272.0K
($1.0M)
Total revenue
$31.2M
$31.5M
$31.1M
$29.1M
Property operating
$5.9M
$6.4M
$5.9M
$5.6M
General and administrative
$4.9M
$5.1M
$4.7M
$10.6M
Depreciation and amortization
$10.7M
$10.7M
$10.9M
$10.9M
Total expenses
$21.5M
$22.1M
$21.5M
$27.0M
Gains on sale, net of loss and impairment of real estate assets
$46.0K
($46.0K)
($888.0K)
—
Interest expense
($7.4M)
($6.8M)
($7.1M)
($6.6M)
Credit loss reserve
$0
—
$0
($8.7M)
Deferred income tax benefit
$12.0K
—
—
—
Interest and other income, net
$3.0K
$3.0K
$7.0K
$5.0K
Total other income (expense)
($7.4M)
($6.8M)
($8.0M)
($14.6M)
NET INCOME (LOSS)
$2.4M
$2.5M
$1.6M
($12.6M)
Net income (loss) per common share - Basic (in dollars per share)
$0.06
$0.07
$0.03
-$0.50
Net income (loss) per common share - Diluted (in dollars per share)
$0.06
$0.07
$0.03
-$0.50
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)
27.0M
27.0M
26.9M
26.8M
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)
27.0M
27.0M
26.9M
26.8M
Balance sheet
Community Healthcare Trust Inc balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Land and land improvements
$154.7M
$149.5M
$136.5M
$117.7M
Buildings, improvements, and lease intangibles
$1.0B
$996.1M
$913.4M
$825.3M
Personal property
$813.0K
$326.0K
$299.0K
$253.0K
Total real estate properties
$1.2B
$1.1B
$1.1B
$943.2M
Less accumulated depreciation
($280.3M)
($242.6M)
($200.8M)
($165.3M)
Total real estate properties, net
$922.9M
$903.3M
$849.4M
$777.8M
Cash and cash equivalents
$3.3M
$4.4M
$3.5M
$11.2M
Assets held for sale
$5.3M
$6.8M
$7.5M
—
Other assets, net
$59.2M
$78.1M
$83.9M
$86.5M
Total assets
$990.8M
$992.6M
$945.4M
$876.4M
Debt, net
$532.2M
$486.0M
$403.3M
$353.0M
Accounts payable and accrued liabilities
$14.9M
$14.3M
$12.0M
$11.4M
Other liabilities, net
$14.2M
$16.4M
$16.9M
$15.2M
Total liabilities
$561.4M
$516.6M
$432.2M
$379.6M
Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding
0
0
0
0
Common stock, $0.01 par value; 450,000 shares authorized; 28,471 and 28,242 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively
285.0K
282.0K
276.0K
259.0K
Additional paid-in capital
$717.5M
$704.5M
$688.2M
$625.1M
Cumulative net income
$90.8M
$85.7M
$88.9M
$81.1M
Accumulated other comprehensive income
$6.7M
$17.6M
$16.4M
$22.7M
Cumulative dividends
($385.8M)
($332.1M)
($280.4M)
($232.4M)
Total stockholders’ equity
$429.4M
$476.0M
$513.3M
$496.8M
Total liabilities and stockholders' equity
$990.8M
$992.6M
$945.4M
$876.4M
Community Healthcare Trust Inc balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Land and land improvements
$163.5M
$162.6M
$154.3M
$152.9M
Buildings, improvements, and lease intangibles
$1.1B
$1.1B
$1.0B
$1.0B
Personal property
$814.0K
$813.0K
$809.0K
$809.0K
Total real estate properties
$1.2B
$1.2B
$1.2B
$1.2B
Less accumulated depreciation
($301.6M)
($291.0M)
($272.5M)
($263.0M)
Total real estate properties, net
$940.0M
$947.1M
$917.7M
$895.4M
Cash and cash equivalents
$2.7M
$2.6M
$3.4M
$4.9M
Assets held for sale, net
$0
$0
$6.2M
$5.5M
Other assets, net
$60.9M
$60.4M
$60.0M
$60.6M
Total assets
$1.0B
$1.0B
$987.3M
$966.3M
Debt, net
$559.3M
$559.3M
$530.1M
$500.1M
Accounts payable and accrued liabilities
$17.7M
$16.4M
$17.2M
$13.9M
Other liabilities, net
$12.3M
$13.1M
$13.1M
$14.5M
Total liabilities
$589.4M
$588.8M
$560.4M
$528.5M
Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding
0
0
0
0
Common stock, $0.01 par value; 450,000 shares authorized; 28,655 and 28,471 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
287.0K
286.0K
285.0K
284.0K
Additional paid-in capital
$722.5M
$719.8M
$714.9M
$712.5M
Cumulative net income
$95.7M
$93.3M
$76.3M
$74.7M
Accumulated other comprehensive income
$9.0M
$7.4M
$7.6M
$9.1M
Cumulative dividends
($413.2M)
($399.5M)
($372.3M)
($358.8M)
Total stockholders’ equity
$414.2M
$421.3M
$426.8M
$437.8M
Total liabilities and stockholders' equity
$1.0B
$1.0B
$987.3M
$966.3M
Cash flow statement
Community Healthcare Trust Inc cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income (loss)
$5.1M
($3.2M)
$7.7M
$22.0M
Depreciation and amortization
$43.5M
$42.8M
$39.7M
$32.3M
Other amortization
$1.3M
$927.0K
$746.0K
$853.0K
Stock-based compensation
$10.3M
$10.0M
$8.2M
$9.4M
Accelerated amortization of stock-based compensation
$4.6M
$0
$11.8M
—
Straight-line rent receivables
($3.7M)
($1.9M)
($3.1M)
($3.4M)
(Gains) on the sales of depreciable real estate assets, net of losses and impairments
($11.8M)
—
—
—
Credit loss reserve
$8.7M
$11.0M
—
—
Net gain from insurance recovery on casualty loss
$0
$0
($706.0K)
—
Deferred income tax expense
$23.0K
$0
$306.0K
$41.0K
Other assets
$994.0K
($3.3M)
($3.0M)
($1.8M)
Accounts payable and accrued liabilities
($1.2M)
$2.3M
$859.0K
$1.4M
Other liabilities
($1.4M)
$221.0K
($1.3M)
($579.0K)
Net cash provided by operating activities
$56.4M
$58.9M
$61.4M
$60.3M
Acquisitions of real estate
($64.6M)
($72.4M)
($98.9M)
($96.7M)
Proceeds from the sale of real estate
$32.2M
$2.3M
$0
—
Funding of notes receivable
$0
($3.1M)
($2.0M)
($9.7M)
Proceeds from repayments on notes receivable
$5.2M
$5.1M
$3.9M
$3.0M
Insurance proceeds from casualty loss
$0
$0
$2.3M
—
Capital expenditures on existing real estate properties
($20.5M)
($24.6M)
($19.0M)
($10.4M)
Net cash used in investing activities
($47.7M)
($92.7M)
($113.7M)
($113.8M)
Net borrowings on revolving credit facility
$46.0M
$162.0M
$50.0M
—
Term loan repayments
$0
($75.0M)
$0
($50.0M)
Mortgage note repayments
$0
($4.8M)
($126.0K)
($130.0K)
Dividends paid
($53.7M)
($51.7M)
($48.1M)
($44.5M)
Proceeds from issuance of common stock
$0
$7.5M
$44.2M
$20.5M
Taxes paid on behalf of employees and shares withheld upon shares vesting
-1.8M
-785.0K
-963.0K
—
Equity issuance costs
($317.0K)
($223.0K)
($227.0K)
($392.0K)
Debt issuance costs
$0
($3.4M)
$0
($844.0K)
Net cash (used in) provided by financing activities
($9.8M)
$33.5M
$44.9M
$62.7M
Decrease in cash, cash equivalents and restricted cash
($1.0M)
($249.0K)
($7.4M)
$9.2M
Cash, cash equivalents and restricted cash, beginning of period
$4.4M
$4.6M
$12.1M
$2.9M
Cash, cash equivalents and restricted cash, end of period
$3.3M
$4.4M
$4.6M
$12.1M
Interest paid
$25.9M
$23.1M
$17.1M
$11.2M
Invoices accrued for construction, tenant improvement and other capitalized costs
$6.6M
$4.6M
$3.9M
$4.4M
Reclassification of registration statement costs to equity issuance costs
$175.0K
—
—
—
(Decrease) increase in fair value of cash flow hedges
($3.9M)
$11.6M
$3.8M
$27.4M
Capitalized interest
$210.0K
$216.0K
$611.0K
$672.0K
Community Healthcare Trust Inc cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income (loss)
$4.9M
$2.5M
($9.3M)
($11.0M)
Depreciation and amortization
$21.4M
$10.7M
$32.7M
$21.8M
Other amortization
$792.0K
$392.0K
$905.0K
$544.0K
Stock-based compensation
$5.5M
$2.7M
$7.7M
$5.2M
Accelerated amortization of stock-based compensation
$0
—
$4.6M
$4.6M
Straight-line rent receivable
($1.4M)
($760.0K)
($2.7M)
($1.8M)
Gains on sale, net of loss and impairment of real estate assets
$0
$46.0K
$248.0K
—
Credit loss reserve
$0
—
$8.7M
$8.7M
Other assets
$1.2M
($591.0K)
$1.2M
$1.7M
Accounts payable and accrued liabilities
$402.0K
($291.0K)
($228.0K)
$558.0K
Other liabilities
($1.6M)
($972.0K)
($2.8M)
($1.5M)
Net cash provided by operating activities
$31.3M
$13.7M
$40.9M
$28.2M
Acquisitions of real estate
($28.5M)
($28.5M)
($36.1M)
($9.7M)
Proceeds from sale of real estate
$6.3M
$5.9M
$1.3M
$615.0K
Proceeds from the repayment of notes receivable
$300.0K
$150.0K
$5.1M
$5.0M
Capital expenditures on existing real estate properties
($9.2M)
($5.0M)
($14.0M)
($8.9M)
Net cash used in investing activities
($31.1M)
($27.5M)
($43.7M)
($13.0M)
Net borrowings on revolving credit facility
$27.0M
$27.0M
$44.0M
$14.0M
Dividends paid
($27.4M)
($13.7M)
($40.1M)
($26.6M)
Taxes paid on behalf of employees and shares withheld upon shares vesting
-398.0K
-298.0K
-1.8M
-1.7M
Equity issuance costs
($32.0K)
($32.0K)
($317.0K)
($317.0K)
Net cash used in financing activities
($849.0K)
$13.0M
$1.8M
($14.7M)
(Decrease) Increase in cash and cash equivalents
($667.0K)
($723.0K)
($1.0M)
$479.0K
Cash and cash equivalents, beginning of period
$3.3M
$3.3M
$4.4M
$4.4M
Cash and cash equivalents, end of period
$2.7M
—
—
—
Interest paid (net of capitalized interest)
$13.7M
$6.5M
$19.2M
$12.4M
Invoices accrued for construction, tenant improvement, and other capitalized costs
$7.7M
$7.9M
$8.7M
$4.1M
Reclassification between other assets and proceeds from sale of real estate
$664.0K
$664.0K
—
—
Reclassification of registration statement costs to equity issuance costs
$85.0K
$43.0K
$139.0K
$121.0K
Increase (decrease) in fair value of cash flow hedges